跳至主要内容
临床试验/IRCT201502122804N8
IRCT201502122804N8已完成3 期

Intermittent furosemide therapy as a prophylaxis of acute renal failure in CABG patients: is it effective? A clinical trial

Vice chancellor for research, Shahid Rajaei Heart Center0 个研究点目标入组 123 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
123

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • age 40-75;
  • elective CABG with CPB;
  • constant surgeon;
  • informed written consent;
  • Exclusion criteria:
  • old age above 75 years;
  • emergency surgery;
  • high risk surgery;
  • ischemic heart disease;
  • diabetes mellitus;
  • diabetic ketoacidosis;
  • non-ketonic hyperosmolar diabetic coma;
  • acute renal failure;
  • chronic kidney disease causing serum Cr>2mg/dL;
  • glomerulonephritis;
  • hepatic failure causing liver function test failure (> 3 times than normal);
  • off pump CABG;
  • any unwanted complication in the operation period;
  • re-starting CPB after weaning from bypass;
  • pulmonary artery pressure >30 before operation;
  • ejection fraction<30%;
  • re-operation in the postoperative period;
  • congestive heart failure;
  • thyroid disorders;
  • acute infections;
  • hospital admission in the recent 3 months;

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shahid Rajaei Heart Center

相似试验